|
Darolutamide plus androgen-deprivation therapy (ADT) in patients with high-risk biochemical recurrence (BCR) of prostate cancer: A phase 3, randomized, double-blind, placebo-controlled study (ARASTEP). |
|
|
Stock and Other Ownership Interests - Vertex (I) |
Honoraria - Advanced Accelerator Applications; Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Curium Pharma; Exelixis; Janssen; Janssen Oncology; Macrogenics; Merck; Myovant Sciences; Pfizer; Sanofi; Telix Pharmaceuticals |
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Exelixis; Janssen; Lantheus Medical Imaging; Merck; Myovant Sciences; Myovant Sciences; Myriad Genetics; Novartis; Sanofi |
Research Funding - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Dendreon; Genentech; Myovant Sciences; Pfizer; Sanofi; Seattle Genetics/Astellas |
Travel, Accommodations, Expenses - Sanofi; Telix Pharmaceuticals |
|
|
Stock and Other Ownership Interests - Knight Pharmaceuticals |
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Merck; Sanofi; Tersera; Tolmar |
Consulting or Advisory Role - Abbvie; AstraZeneca Canada; Bayer; Janssen Oncology; Sanofi; Tersera |
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Sanofi (Inst); Tersera (Inst) |
Travel, Accommodations, Expenses - Janssen Oncology; Sanofi; Tersera |
|
|
|
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Peerview; Pfizer; Photocure; PlatformQ Health; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma |
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow |
|
|
Honoraria - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag |
Consulting or Advisory Role - Bayer Schering Pharma; Bristol-Myers Squibb; Janssen-Cilag |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Blue Earth Diagnostics; Decipher Biosciences; Janssen Biotech; Lantheus Medical Imaging; Myovant Sciences; tempus |
Consulting or Advisory Role - Astellas Pharma; BillionToOne |
Speakers' Bureau - Tempus |
|
|
Stock and Other Ownership Interests - Curium Pharma; RayzeBio |
Honoraria - GE Healthcare |
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Curium Pharma; Ipsen; ITM Isotope Technologies Munich; Lantheus Medical Imaging |
Research Funding - Advanced Accelerator Applications (Inst); Clovis Oncology (Inst); GE Healthcare (Inst); Janssen Oncology (Inst); Lantheus Medical Imaging (Inst); Novartis (Inst); Philips Healthcare (Inst); Telix Pharmaceuticals (Inst) |
Travel, Accommodations, Expenses - GE Healthcare |
|
|
Honoraria - ASCO; EPG Health; Medical Oncology Association of Southern California; OncLive/MJH Life Sciences |
Consulting or Advisory Role - Aveo Inc; Eisai; Exelixis; Seagen |
Speakers' Bureau - Exelixis |
Research Funding - Exelixis |
Travel, Accommodations, Expenses - Bayer |
|
|
Honoraria - Astellas Pharma; Bayer; Ferring; Ipsen; Janssen; MSD; Novartis |
Consulting or Advisory Role - Astellas Pharma; Bayer; Ferring; Ipsen; Janssen; MSD; Novartis |
Research Funding - Astellas Pharma; AstraZeneca; Janssen |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ferring; Ipsen; Janssen; MSD; Novartis |
|
|
Honoraria - Astellas Pharma; Bayer; BMS; Gilead Sciences; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; SEAGEN |
Consulting or Advisory Role - AAA/Endocyte/Novartis; Amgen; AstraZeneca; Bayer; BMS; Eisai; Gilead Sciences; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer |
Research Funding - IPSEN (Inst) |
Travel, Accommodations, Expenses - BMS; IPSEN; Janssen-Cilag; Merck/Pfizer; MSD; Pfizer |
|
|
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ferring; Johnson & Johnson; MSD; Orion; Pfizer |
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ferring; Johnson & Johnson; MSD; Orion; Pfizer |
Research Funding - Bayer; MSD; Pfizer |
Travel, Accommodations, Expenses - Intuituve; Medtronic |
|
|
Honoraria - Adium Pharma; Adium Pharma; Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology |
Consulting or Advisory Role - Bayer; Janssen Oncology |
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology |
Research Funding - AstraZeneca; Bayer; Janssen Oncology; MSD Oncology; Roche |
Travel, Accommodations, Expenses - Janssen Oncology |
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Johnson & Johnson; MSD |
Speakers' Bureau - Astellas Pharma; Bayer; Johnson & Johnson |
Research Funding - Johnson & Johnson |
Travel, Accommodations, Expenses - Bayer; Ipsen; Johnson & Johnson; Recordati |
|
|
Consulting or Advisory Role - Bayer; Knight Therapeutics; Tolmar |
|
|
Carmen Belen Congregado Ruiz |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
|
Employment - Bayer Germany |
Stock and Other Ownership Interests - Bayer; Bayer |
|
|
Honoraria - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Novartis (Inst) |
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Janssen Oncology (Inst); MSD (Inst); Novartis (Inst); Orion; Pfizer (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Janssen; MSD; Pfizer |